Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
15000 participants
OBSERVATIONAL
2025-04-01
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
key scientific questions:
1. The 95th and 99th percentile of finger blood TC in children of 2 years old.
2. Mutations that contribute to high TC status ( serum TC \>99th percentiles) compared with international FH48 panel for FH genetic screening.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Announcement of Rare Metabolic Diseases in Systematic Newborn Screening: the Phenylketonuria Experience.
NCT06289348
Community-Based Interventions for Infant Health in Nepal
NCT00656591
Family Genetics Health Education and Healthy Behaviors
NCT01498276
Enhancing Safe Sleep Practices of Urban Low-Income Mothers
NCT03070639
Assessing the Feasibility of Integrating Maternal Nutrition Interventions Into an Existing MNCH Platform in Bangladesh
NCT02745249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Child-parent screening strategy in our study consists three steps: i. Capillary blood total cholesterol test of children aged around 2 years; ii. re-test for children with cholesterol\>95th percentile in the first step; iii. WES (whole exome sequencing) test for \>P99 in the first two steps. iV: TC test and mutation test to the parents of the child FH cases. The investigators will determine FH families based on the program. Children's Hospital of Fudan University will provide treatment further.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
FAMILY_BASED
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no interventions
it is a observational study, do not have interventions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* aged 1 - 3 years old ( date of investigate minus date of birth)
Exclusion Criteria
1 Year
3 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
LIling Qian, Master
Role: STUDY_DIRECTOR
Children's Hospital of Fudan University
Rui Dong, MD
Role: STUDY_DIRECTOR
Children's Hospital of Fudan University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anhui Provincial Children's Hospital
Hefei, Anhui, China
Qidong Women and Children Hospital
Qidong, Jiangsu, China
Weili Yan
Shanghai, Shanghai Municipality, China
Shanxi Provincial Children's Hospital
Taiyuan, Shanxi, China
Chongqin Medical University Affiliated Children's Hospital
Chongqing, Sichuan, China
Urumqi Children's Hospital
Ürümqi, Xinjiang, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Haipeng Liu
Role: primary
Jun Shen
Role: primary
YI Zhang, PhD
Role: primary
Lixia Bai
Role: primary
Xiaohua Liang
Role: primary
Wenping Cai
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHFD-2020007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.